Vanda Pharmaceuticals
VNDA
#7866
Rank
A$0.40 B
Marketcap
$6.92
Share price
-1.34%
Change (1 day)
4.79%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -A$55.65 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. In 2023 the company made an earning of -A$21.79 Million a decrease over its 2022 earnings that were of A$9.88 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$55.65 Million155.41%
2023 -A$21.79 Million-320.45%
2022 A$9.88 M-84.99%
2021 A$65.84 M54.8%
2020 A$42.53 M19.42%
2019 A$35.61 M4.93%
2018 A$33.94 M-228.6%
2017 -A$26.4 Million-8.98%
2016 -A$29 Million-53.79%
2015 -A$62.75 Million-30.18%
2014 -A$89.88 Million173.08%
2013 -A$32.92 Million-25.33%
2012 -A$44.08 Million163.61%
2011 -A$16.72 Million-221.15%
2010 A$13.8 M-124.53%
2009 -A$56.27 Million-29.44%
2008 -A$79.74 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$0.11 Billion170.55%
2005 -A$37.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$21.29 B-36,497.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$15.85 B-27,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.23 B-46,643.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.09 Billion 22,258.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.84 B-18,627.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$9.2 Million-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.38 B-40,054.64%๐Ÿ‡บ๐Ÿ‡ธ USA